- About Welchol
- LDL-C and A1C Reductions
- Register For Updates
Welchol® (colesevelam HCl) is the only therapy suggested by the AACE† in 2013 as an
add-on to a statin and metformin to lower LDL-C and A1C.1
†AACE=American Association of Clinical Endocrinologists.
The photos depict models, not actual patients or healthcare professionals.
Would you like to
request samples and patient resources now?
You are leaving WelcholHCP.com
Please Note: You are about to leave the WelcholHCP.com website by opening a new page. Daiichi Sankyo, Inc. does not control the content of the website connected to this link.cancel continue